Department of Clinical Laboratory, Kunshan Hospital of Chinese Medicine, Affiliated Hospital of Yangzhou University, Kunshan, China.
Front Cell Infect Microbiol. 2023 Oct 4;13:1249038. doi: 10.3389/fcimb.2023.1249038. eCollection 2023.
The coronavirus disease 2019 (COVID-19) pandemic is a rapidly evolving global emergency and continuously poses a serious threat to public health, highlighting the urgent need of identifying biomarkers for disease severity and progression. In order to early identify severe and critical patients, we retrospectively analyze the clinical characteristics and risk indicators of severe disease in patients with corona virus disease 2019 (COVID-19).
A total of 420 confirmed COVID-19 patients were included in the study. According to the "Diagnosis and Treatment of novel coronavirus Pneumonia (10th Edition)", the cases were divided into mild group (n = 243) and severe group (n =177). Laboratory parameters were analyzed in combination with clinical data.
Male patients over 46 years who have smoking habits were more likely to suffer from severe COVID-19. Critically ill patients had lower lymphocyte counts and red blood cell counts, and higher white blood cell counts (P<0.05). Expectedly, serum inflammatory factors (NLR, PLR, LMR, CLR, PCT, CRP), coagulation markers (APTT, PT, TT, FIB, D-Dimer), Myocardial damage markers (hs-TNT, LDH) were significantly increased (P<0.05) in severe COVID-19 patients. Surprisedly, those patients showed obviously elevated levels of common tumor markers (ProGRP, CYFRA21-1, SCC, NSE) (P<0.05). In this case, the levels of tumor marker reflected more the condition of inflammation than the growth of tumor. More importantly, HA and PIIIN-P were highly associated with COVID-19 severity. The AUC of the ROC curve for the diagnosis of severe COVID-19 by HA and PIIIN-P was 0.826. Meanwhile, HA was positively correlated with myocardial damage markers (hs-TNT, LDH). PIIIN-P was positively correlated with myocardial damage markers (hs-TNT, LDH) and inflammatory factors (NLR, PLR, LMR, CLR, ProGRP, SCC, PCT, CRP). On the contrary, PIIIN-P was negatively correlated with pulmonary function indexes (oxygenation index and oxygen saturation of hemoglobin).
HA and PIIIN-P are highly associated with disease severity and progression of COVID-19 and can be used as new markers for the prediction of severe COVID-19.
2019 年冠状病毒病(COVID-19)大流行是一场迅速演变的全球紧急事件,持续对公共卫生构成严重威胁,凸显出确定疾病严重程度和进展的生物标志物的紧迫性。为了尽早识别重症和危重症患者,我们回顾性分析了确诊的 2019 年冠状病毒病(COVID-19)患者的临床特征和疾病严重程度的风险指标。
本研究共纳入 420 例确诊的 COVID-19 患者。根据《新型冠状病毒肺炎诊疗方案(试行第十版)》,将病例分为轻症组(n = 243)和重症组(n = 177)。结合临床资料分析实验室参数。
年龄>46 岁、有吸烟史的男性更易发生重症 COVID-19。危重症患者的淋巴细胞计数和红细胞计数较低,白细胞计数较高(P<0.05)。预期的血清炎症因子(NLR、PLR、LMR、CLR、PCT、CRP)、凝血标志物(APTT、PT、TT、FIB、D-二聚体)、心肌损伤标志物(hs-TNT、LDH)在重症 COVID-19 患者中显著升高(P<0.05)。令人惊讶的是,这些患者常见肿瘤标志物(ProGRP、CYFRA21-1、SCC、NSE)水平明显升高(P<0.05)。在这种情况下,肿瘤标志物的水平更多地反映了炎症状况,而不是肿瘤的生长。更重要的是,HA 和 PIIIN-P 与 COVID-19 的严重程度高度相关。HA 和 PIIIN-P 诊断重症 COVID-19 的 ROC 曲线下面积为 0.826。同时,HA 与心肌损伤标志物(hs-TNT、LDH)呈正相关。PIIIN-P 与心肌损伤标志物(hs-TNT、LDH)和炎症因子(NLR、PLR、LMR、CLR、ProGRP、SCC、PCT、CRP)呈正相关。相反,PIIIN-P 与肺功能指标(氧合指数和血红蛋白氧饱和度)呈负相关。
HA 和 PIIIN-P 与 COVID-19 的严重程度和进展高度相关,可作为预测重症 COVID-19 的新标志物。